Share-based Payment Arrangements | (2) Share-based Payment Arrangements As of June 25, 2022, the Company has an employee equity incentive plan, the 2011 equity incentive plan (the “2011 EIP”). The Company also had two stock compensation plans for members of its Board of Directors, the Amended and Restated 2013 Directors Stock Compensation Plan (as amended and restated as of May 17, 2016, the “2013 DSCP”) and the 2022 Directors Stock Compensation Plan (the “2022 DSCP”), which replaced the 2013 DSCP. At the Company’s 2022 Annual Meeting of Stockholders held on May 11, 2022, the Company’s stockholders approved the 2022 DSCP. The provisions of the 2022 DSCP are substantially similar to the provisions of the 2013 DSCP. 6,000,000 shares of the Company’s common stock were authorized for issuance under the 2011 EIP, and 200,000 shares of the Company’s common stock were authorized for issuance under the 2022 DSCP. No further grants can be made under the 2013 DSCP, including 56,502 shares of the C c s Twenty Six Weeks Thirteen Weeks June 25, 2022 June 26, 2021 June 25, 2022 June 26, 2021 Total cost of the Plans during the period $ 5,810 $ 10,893 $ 3,815 $ 6,864 Amount of related income tax benefit recognized during the period (4,270 ) (3,717 ) (910 ) (2,376 ) Net cost of the Plans during the period $ 1,540 $ 7,176 $ 2,905 $ 4,488 Included in income tax benefits recognized in the twenty-six- As of June 25, 2022, there were 193,217 shares of the Company’s common stock reserved for issuance under the 2022 DSCP and 3,233,908 shares of the Company’s common stock reserved for issuance under the 2011 EIP. Restricted Stock Units The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans: Number of Weighted Average Grant Date Fair Value Outstanding at December 25, 2021 209,399 $ 102.90 Granted 49,596 $ 139.67 Shares earned in excess of target (1) 91,497 $ 92.58 Vested shares, including shares earned in excess of target (174,366 ) $ 96.14 Forfeited (16,768 ) $ 105.35 Outstanding at June 25, 2022 159,358 $ 115.55 (1) Represents additional shares earned under each of the February 2, 2017; February 2, 2018 and February 1, 2019 RSU awards as fiscal year 2021 financial results exceeded target performance level. During the twenty-six-week 10-K. RSUs with a performance condition granted on January 28, 2022 may vest on January 31 of 2025, 2026 and 2027 based on growth in operating income and pre-tax The Company recognized approximately $4,203,000 and $9,249,000 of share-based compensation expense related to RSU awards in the twenty-six-week Non-vested The following table summarizes information regarding the Company’s outstanding shares of non-vested Number of Shares and Deferred Stock Weighted Average Grant Date Fair Value Non-vested 56,436 $ 125.16 Granted 23,791 $ 153.11 Vested (27,074 ) $ 122.68 Forfeited (2,302 ) $ 108.59 Non-vested 50,851 $ 140.31 The fair value of each share of non-vested non-vested As of June 25, 2022, there was $5,692,000 of total unrecognized compensation cost related to non-vested non-vested Stock Options The following table summarizes information regarding the Company’s outstanding stock options under the Plans: Number of Weighted Average per Share Weighted Average Term (years) Aggregate Intrinsic Options outstanding at December 25, 2021 8,570 $ 55.42 Exercised (3,500 ) $ 54.01 Options outstanding at June 25, 2022 5,070 $ 56.40 0.6 $ 464 Options exercisable at June 25, 2022 5,070 $ 56.40 0.6 $ 464 The total intrinsic value of stock options exercised during the twenty-six-week As of June 25, 2022, there was no unrecognized compensation cost related to stock options granted under the Plans. |